DIUXF (Diaceutics) Other Long-Term Liabilities: $0.13 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DIUXF Diaceutics PLC DIUXF
80 GF Score
Price $2.00
GF Value $2.06
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Diaceutics Other Long-Term Liabilities?

Diaceutics DIUXF 80 Other Long-Term Liabilities is $0.13 Mil as of Dec. 2025. GuruFocus rates DIUXF with a GF Score™ of 80/100 and a GF Value™ of $2.06 (Fairly Valued). The stock has 1 warning sign investors should review.

Diaceutics's other long-term liabilities for the quarter that ended in Dec. 2025 was $0.13 Mil.

Diaceutics's quarterly other long-term liabilities increased from Dec. 2024 ($0.11 Mil) to Jun. 2025 ($0.13 Mil) and increased from Jun. 2025 ($0.13 Mil) to Dec. 2025 ($0.13 Mil).

Diaceutics's annual other long-term liabilities declined from Dec. 2023 ($0.15 Mil) to Dec. 2024 ($0.11 Mil) but then increased from Dec. 2024 ($0.11 Mil) to Dec. 2025 ($0.13 Mil).

Diaceutics Other Long-Term Liabilities Related Terms

Diaceutics Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Diaceutics's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diaceutics Other Long-Term Liabilities Chart

Diaceutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.59 0.96 0.15 0.11 0.13

Diaceutics Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.11 0.11 0.13 0.13
DIUXF
80GF Score
Diaceutics PLC DIUXF
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diaceutics Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of $0.13 Mil mean?
Diaceutics (DIUXF) has a Other Long-Term Liabilities of $0.13 Mil as of Dec. 2025. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Diaceutics and its competitors.
Is Diaceutics' Other Long-Term Liabilities too high?
Diaceutics' current Other Long-Term Liabilities is $0.13 Mil. Overall, Diaceutics has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Diaceutics' Other Long-Term Liabilities compare to VEEV and BTSG?
Diaceutics' Other Long-Term Liabilities of $0.13 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Healthcare Providers & Services company?
A good Other Long-Term Liabilities depends on the Healthcare Providers & Services industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Diaceutics and its competitors. Diaceutics's current Other Long-Term Liabilities is $0.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diaceutics stock overvalued right now?
Based on GuruFocus' analysis, Diaceutics (DIUXF) is currently considered Fairly Valued. The stock's GF Value™ is $2.06, compared to a current price of $2.00 — trading 2.9% below its estimated fair value. The current Other Long-Term Liabilities is $0.13 Mil. Diaceutics' overall GF Score™ is 80/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Diaceutics (DIUXF), the current Other Long-Term Liabilities is $0.13 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Diaceutics (DIUXF) Overvalued in 2026?

Based on GuruFocus' analysis, Diaceutics stock appears to be undervalued. The current stock price of $2.00 is trading 2.9% below its estimated GF Value™ of $2.06. GuruFocus considers Diaceutics to be Fairly Valued.

Key valuation signals for DIUXF:

  • Other Long-Term Liabilities: $0.13 Mil
  • GF Value™: $2.06 vs. price of $2.00 (2.9% below fair value)
  • GF Score™: 80/100 with 1 warning sign

No single metric tells the full story. See the DIUXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Diaceutics Business Description

Other Exchanges DXRX:UK7DC:Germany
Address Dataworks at Kings Hall Health & Wellbeing Park, First Floor, Building Two, County Antrim, Belfast, GBR, BT9 6GW
Diaceutics PLC is a data analytics and implementation services company that services the pharmaceutical industry. It provides integrated commercialization solutions that help biopharma companies maximize patient access, accelerate uptake, and improve the lifetime value of their therapies. The group's services span the full commercial lifecycle, from pre-launch ideas through to mature brand optimization, delivered through an integrated combination of data, technology, and expertise. Its DXRX Data Solutions include DXRX Signal, DXRX Physician Segmentation, DXRX Lab Segmentation, and DXRX Disease Testing Rate Tracker. Geographical market by customer location in the UK, North America, Europe, Asia, and the rest of the world.
80GF Score

Get the complete analysis for DIUXF

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.00
Price
$2.06
GF Value